BioWorld

July 11, 2011

View Archived Issues

BioLineRx Trades IPO for ADR To Access Investors, Partners

Read More

New Fentanyl Approvals Hint At Track for Class-Wide REMS

Read More

Money Raised By Biotech in 2011

Read More

Week in Review

Read More

Word on the Street

Read More

FDA Approvals in June

Read More

Phase I Clinical Trials Update: June 2011

Read More

Phase II Clinical Trials Update: June 2011

Read More

Phase III Clinical Trials Update: June 2011

Read More

American Diabetes Association

Read More

American Society of Clinical Oncology

Read More

Public Biotechs Drive Funding Increase in H1 2011 v. H1 2010

Biotech companies raised a total of $13.3 billion in the first half of 2011, reclaiming much of the fundraising ground that was lost when the markets crashed in 2008. Read More

Money Raised Year to Date

Read More

Non-U.S. Clinical Trials & Regulatory Actions: June 2011

Read More

FDA Submissions, Approvals & Other Actions: June 2011

Read More

Stock Gainers and Losers For The Week

Read More

BioWorld Stock Report For Public Biotechnology Companies

Read More